Mettler-Toledo International Inc. (NYSE:MTD) Receives Average Recommendation of “Hold” from Analysts

Shares of Mettler-Toledo International Inc. (NYSE:MTD) have been assigned an average rating of “Hold” from the eight ratings firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $1,256.25.

A number of equities research analysts have recently issued reports on MTD shares. Jefferies Financial Group reaffirmed an “underperform” rating and set a $1,250.00 target price (up from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. Stifel Nicolaus upped their price target on Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the stock a “buy” rating in a research note on Monday, May 13th. Robert W. Baird upped their price target on Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the stock a “neutral” rating in a research note on Monday, May 13th. Citigroup boosted their price objective on Mettler-Toledo International from $975.00 to $1,200.00 and gave the stock a “sell” rating in a research report on Monday, May 13th. Finally, Evercore ISI boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the stock an “in-line” rating in a research report on Thursday, April 4th.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $1,457.07, for a total value of $437,121.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $7,160,041.98. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Thomas P. Salice sold 1,268 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $1,490.18, for a total value of $1,889,548.24. Following the transaction, the director now owns 244 shares of the company’s stock, valued at approximately $363,603.92. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $1,457.07, for a total value of $437,121.00. Following the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $7,160,041.98. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,278 shares of company stock valued at $4,871,849. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several hedge funds and other institutional investors have recently modified their holdings of MTD. Capital International Investors boosted its holdings in shares of Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after acquiring an additional 141,431 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Mettler-Toledo International by 169.4% in the first quarter. Bank of New York Mellon Corp now owns 573,702 shares of the medical instruments supplier’s stock worth $763,764,000 after purchasing an additional 360,786 shares during the last quarter. Morgan Stanley grew its stake in shares of Mettler-Toledo International by 9.6% in the third quarter. Morgan Stanley now owns 267,167 shares of the medical instruments supplier’s stock worth $296,041,000 after purchasing an additional 23,305 shares during the last quarter. Norges Bank bought a new stake in Mettler-Toledo International during the fourth quarter valued at $320,847,000. Finally, Principal Financial Group Inc. raised its holdings in shares of Mettler-Toledo International by 2.8% during the first quarter. Principal Financial Group Inc. now owns 248,007 shares of the medical instruments supplier’s stock valued at $330,169,000 after purchasing an additional 6,788 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,397.59 on Friday. Mettler-Toledo International has a 12-month low of $928.49 and a 12-month high of $1,535.86. The business has a 50 day simple moving average of $1,399.77 and a 200 day simple moving average of $1,292.08. The firm has a market capitalization of $29.85 billion, a P/E ratio of 39.19, a P/E/G ratio of 3.83 and a beta of 1.20.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.61 by $1.28. Mettler-Toledo International had a negative return on equity of 662.32% and a net margin of 20.55%. The company had revenue of $925.95 million during the quarter, compared to analyst estimates of $879.72 million. During the same quarter in the previous year, the firm posted $8.69 EPS. The firm’s quarterly revenue was down .3% on a year-over-year basis. Research analysts anticipate that Mettler-Toledo International will post 40.13 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.